PMC Links for Books (Select 4864850) - PMC

Select item 96350351.

Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events

Kantaro Ishitsuka, Yasuhisa Yokoyama, Naoko Baba, Ryota Matsuoka, Noriaki Sakamoto, Tatsuhiro Sakamoto, Manabu Kusakabe, Takayasu Kato, Naoki Kurita, Hidekazu Nishikii, Mamiko Sakata-Yanagimoto, Naoshi Obara, Yuichi Hasegawa, Shigeru Chiba

J Clin Exp Hematop. 2022 Sep; 62(3): 154–157. Published online 2022 Jul 12. doi: 10.3960/jslrt.21035

PMCID:: PMC9635035

Abstract Article PDF–2.1M

Select item 63888932.

Brentuximab vedotin in combination with sequential procarbazine, cyclophosphamide and prednisolone for the management of Hodgkin’s lymphoma-associated vanishing bile duct syndrome (VBDS) with severe obstructive liver failure

Min Fong, Stephen Boyle, Naadir Gutta

BMJ Case Rep. 2019; 12(2): e227676. Published online 2019 Feb 21. doi: 10.1136/bcr-2018-227676

PMCID:: PMC6388893

Abstract Article PDF–1.5M

Select item 50891603.

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Youn H. Kim, Mahkam Tavallaee, Uma Sundram, Katrin A. Salva, Gary S. Wood, Shufeng Li, Sima Rozati, Seema Nagpal, Michael Krathen, Sunil Reddy, Richard T. Hoppe, Annie Nguyen-Lin, Wen-Kai Weng, Randall Armstrong, Melissa Pulitzer, Ranjana H. Advani, Steven M. Horwitz

J Clin Oncol. 2015 Nov 10; 33(32): 3750–3758. Published online 2015 Jul 20. doi: 10.1200/JCO.2014.60.3969

PMCID:: PMC5089160

Abstract Article PDF–4.2M

Select item 46394104.

Results of a multicenter phase II trial of brentuximab vedotin as second-line therapy before autologous transplantation in relapsed/refractory Hodgkin Lymphoma

Robert Chen, Joycelynne M. Palmer, Peter Martin, Nicole Tsai, Young Kim, Bihong T. Chen, Leslie Popplewell, Tanya Siddiqi, Sandra H. Thomas, Michelle Mott, Firoozeh Sahebi, Saro Armenian, John Leonard, Auayporn Nademanee, Stephen J. Forman

Biol Blood Marrow Transplant. Author manuscript; available in PMC 2016 Dec 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2015 Dec; 21(12): 2136–2140. Published online 2015 Jul 26. doi: 10.1016/j.bbmt.2015.07.018

PMCID:: PMC4639410

Abstract Article PDF–685K

Select item 44608315.

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Kenneth R. Carson, Scott D. Newsome, Ellen J. Kim, Nina D. Wagner-Johnston, Gloria von Geldern, Craig H. Moskowitz, Alison J. Moskowitz, Alain H. Rook, Pankaj Jalan, Alison W. Loren, Daniel Landsburg, Thomas Coyne, Donald Tsai, Dennis W. Raisch, LeAnn B. Norris, P Brandon Bookstaver, Oliver Sartor, Charles L. Bennett

Cancer. Author manuscript; available in PMC 2015 Aug 15.

Published in final edited form as: Cancer. 2014 Aug 15; 120(16): 2464–2471. Published online 2014 Apr 25. doi: 10.1002/cncr.28712

PMCID:: PMC4460831

Abstract Article PDF–132K

Select item 44462356.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 39642967.

Acute Pancreatitis Following Brentuximab Vedotin Therapy for Refractory Hodgkin Lymphoma: A Case Report

S. A. M. Urru, E. Mariotti, P. Carta, S. Massidda, M. Marcias, R. Murru, P. Sanna, E. Angelucci

Drugs R D. 2014 Mar; 14(1): 9–11. Published online 2014 Feb 4. doi: 10.1007/s40268-014-0036-x

PMCID:: PMC3964296

Article PDF–184K

Select item 37316518.

Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation

Ajay K. Gopal, Radhakrishnan Ramchandren, Owen A. O'Connor, Robert B. Berryman, Ranjana H. Advani, Robert Chen, Scott E. Smith, Maureen Cooper, Achim Rothe, Jeffrey V. Matous, Laurie E. Grove, Jasmine Zain

Blood. 2012 Jul 19; 120(3): 560–568. Prepublished online 2012 Apr 17. doi: 10.1182/blood-2011-12-397893

PMCID:: PMC3731651

Abstract Article

Select item 36463169.

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith, Stephen M. Ansell, Joseph D. Rosenblatt, Kerry J. Savage, Radhakrishnan Ramchandren, Nancy L. Bartlett, Bruce D. Cheson, Sven de Vos, Andres Forero-Torres, Craig H. Moskowitz, Joseph M. Connors, Andreas Engert, Emily K. Larsen, Dana A. Kennedy, Eric L. Sievers, Robert Chen

J Clin Oncol. 2012 Jun 20; 30(18): 2183–2189. Published online 2012 Mar 26. doi: 10.1200/JCO.2011.38.0410

PMCID:: PMC3646316

Abstract Article PDF–249K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 9

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity